Skip to content

Predictors for efficient ICU use after pulmonary surgery: a retrospective multicenter study

Predictors for efficient ICU use after pulmonary surgery: a retrospective multicenter study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON21274
Enrollment
500
Registered
2018-05-14
Start date
2018-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary surgery, intensive care, effective intensive care use, adverse events

Interventions

None listed

Sponsors

Amphia Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients that underwent elective pulmonary surgery (pneumonectomy, (bi)(sleeve)lobectomy, segmentectomy), with a postoperative admission to the ICU are included.

Exclusion criteria

Exclusion criteria: Intraoperative death.

Design outcomes

Primary

MeasureTime frame
-invasive mechanical ventilation (initiated on the ICU or continued from the operating theatre for at least 3 hours) -non-invasive mechanical ventilation (use of continuous positive airway pressure) -reintubation -use of high-flow nasal oxygen therapy Optiflow) -pneumothorax requiring (new) chest tube insertion or repositioning chest tube -need for bronchoscopy -bleeding requiring intervention (requiring surgery or transfusion of blood (clotting) products) -reoperation -supraventricular arrhythmia (new-onset atrial fibrillation or atrial flutter) with hemodynamic impairment -congestive heart failure (pleural effusion or pulmonary edema requiring diuretic therapy) -myocardial infarction (elevated hs-cTn in combination with clinical symptoms or electrocardiography changes) -hemodynamic instability requiring the use of vasopressors or inotropes

Secondary

MeasureTime frame
-pneumonia (purulent sputum, positive sputum or blood culture and clinical symptoms such as cough, fever or consolidation on chest radiograph) -pulmonary empyema (pleural effusion and the presence of pus on pleural aspiration, microorganism on pleural fluid culture or positive pleural fluid Gram stain) -sepsis (qSOFA score &#8805;2 in response to an infection) -wound infection (purulent drainage from superficial incision or deliberate opening of superficial incision by surgeon and pain, tenderness, swelling or redness) -urinary tract infection (urinary tract symptoms or fever and urine culture with no more than 2 species of organisms identified with at least one of which is a bacterium of &#8805;105 CFU/ml) -acute kidney injury (increase in serum creatinine by &#8805; 26 µmol/l, a percentage increase in serum creatinine of more than or equal to 50% or oliguria of less than 0.5 ml/kg per hour for more than six hours within 48 hours) -respiratory insufficiency (hypoxia or hypercapnia leading to ICU (re)admission) -reoperation -supraventricular arrhythmia (new-onset atrial fibrillation or atrial flutter) -congestive heart failure (pleural effusion or pulmonary edema requiring diuretic therapy) -acute respiratory distress syndrome (defined as diffuse inflammatory lung injury (onset over 1 week or less), bilateral opacities consistent with pulmonary edema must be present and may be detected on CT or chest radiograph, PF ratio <300mmHg with a minimum of 5 cmH20 PEEP (or CPAP) must not be fully explained by cardiac failure or fluid overload -pulmonary embolus (filling defect &#8805; 75% in a pulmonary artery with corresponding normal ventilation -stroke (clinical diagnosis of acute transient ischemic attack (TIA) or cerebrovascular accident (CVA)) -myocardial infarction (elevated hs-cTn in combination with clinical symptoms or electrocardiography changes) -mortality

Contacts

Public ContactThijs Rettig

Amphia Hospital

trettig@amphia.nl0765955637

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)